BOSTON (Reuters) - Injections of an enzyme that breaks up collagen can unlock permanently curled fingers for people with a common disabling condition known as Dupuytren's contracture, U.S. researchers ...
Novartis obtained portfolio-level options for exclusive rights to Hybrozyme-enabled SC formulations, with economics up to ...
YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Clinigen K.K. (“Clinigen”), headquartered in ...
The Chosun Ilbo on MSN
Alteogen secures up to $3.223B Novartis subcutaneous injection deal
Alteogen has exported technology to global pharmaceutical company Novartis to convert intravenous injections into simpler ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results